Molecular Partners posts Gordon Research Conference Radio-DARPins presentation on website
MOLN•Gordon Research Conference presentation posted
Molecular Partners published the Gordon Research Conference presentation, “Appropriate Targets for RLT? High selectivity vs high expression,” by Daniel Steiner.
- Slides outline Radio-DARPin design to match target biology via optimized binding, systemic half-life, and biodistribution, aiming to improve outcomes.
- Updates include bispecific Radio-DARPins and 2-in-1 DuoDARPin formats to address tumor heterogeneity by engaging multiple targets.
- Lead program MP0712 (DLL3) remains in a U.S. Phase 1/2a trial; MP0726 (MSLN) targets membrane-bound MSLN, with first human imaging expected this year.
The presentation is available at Scientific Documents.
Related News
HCA Healthcare Inc <HCA.N>: Jefferies cuts target price to $450 from $525
HCA•
Paj President Given Current Configuration Of Japan's Refineries, Which Are Better Suited To Processing Middle Eastern Grades, It Is Difficult To Handle Large Volumes Of U.S. Crude Now
XLE•
